Uoh Startup Transcell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Significantly improved patient survival and time to recovery observed following the treatment, says Transcell Oncologics
A breakthrough human Umbilical Cord (UC) tissue harvested and clinically processed adult Mesenchymal Stem Cells (MSCs)-based therapy to COVID patients has been announced by Transcell Oncologics,
a biotech start-up company, incubated at ASPIRE-Technology Business Incubator (ASPIRE-TBI), University of Hyderabad (UoH) on Monday.
The firm had developed proprietary cell-based platform technology ‘HEMATO UC-MSCs’ with anti-cytokine storm properties, anti-inflammatory attributes and repairing abilities. The research recommends HEMATO UC-MSCs to be administered as “two intravenous infusions, at a dose of 100 million cells per infusion, given 72 hours apart to the COVID patients. ....

United States , Andhra Pradesh , Subadra Dravida , Transcell Oncologics , Rao Podile , Cell Transplant Centre , University Of Hyderabad Uo , Umiami Miller School Of Medicine , Jackson Health System , Department Of Public Health Sciences , Umbilical Cord , Mesenchymal Stem Cells , Technology Business Incubator , Miami Miller School , Public Health Sciences , Acute Respiratory Distress Syndrome , Controlled Trial , Uoh Startup Transcell , Human Umbilical Cord Uc Tissue , Mesenchymal Stem Cells Mscs Based Therapy , Covid Patients , Aspire Technology Business Incubator , University Of Hyderabad , Emato Uc Mscs , Appa Rao Podile , ஒன்றுபட்டது மாநிலங்களில் ,